Kohl's Corp. (KSS)
NYSEConsumer DiscretionaryDepartment StoresSnapshot 2026-09-15
$16.36-4.72%
Close 2026-09-15 · 1-day change
NYSEConsumer DiscretionaryDepartment StoresSnapshot 2026-09-15
Research Workspace
Put KSS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 3% on a typical day and fell roughly 52% in its worst 12-month stretch.
View RiskKohl's must continue improving operational performance and comparable sales to justify its price. Revenue growth has been steady, with the latest quarter beating estimates significantly. It trades at 7.4× P/E versus a peer median of 14.6×, indicating that the price reflects less growth than forecasted. If Kohl's cuts guidance on the next call, that could negatively impact expectations. Peer multiples imply a price about 63% above where it trades. Our read remains intact.
Trailing returns as of 2026-09-15. KSS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 14 analysts currently covering KSS (as of Sep 2026).
Based on 4 Wall Street analysts offering 12-month price targets for KSS in the last 4 months.
Continue this research
Compare KSS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| KSS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-09-15. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Broadline Retail — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put KSS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Improve operational performance and comparable sales
New partnerships may improve operational performance and sales.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
Current $16.36
The last 12 months of price, then the range of analyst 12-month targets from today’s $16.36.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Board refreshment and leadership transitions
New leadership may improve operational performance and sales.
Threatens: Improve operational performance and comparable sales
18 straight losing quarters indicate ongoing operational struggles.
Advances: Improve operational performance and comparable sales
Expansion in Sephora boosts sales potential and operational performance.
Advances: Improve operational performance and comparable sales
New partnership may improve operational performance and sales.
Advances: Improve operational performance and comparable sales
Raised outlook indicates improved operational performance and sales growth.
Advances: Improve operational performance and comparable sales
Strategic investments improve operational performance and sales growth.
Advances: Achieve earnings beat and improve operational performance
Earnings beat improves operational performance outlook.
